New Potomac Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $59.1K | Buy |
+300
| New | +$59.1K | 0.03% | 115 |
|
|
2022
Q1 | – | Sell |
-550
| Closed | -$207K | – | 62 |
|
|
2021
Q4 | $207K | Sell |
550
-150
| -21% | -$56.5K | 0.13% | 60 |
|
|
2021
Q3 | $289K | Sell |
700
-50
| -7% | -$20.6K | 0.2% | 59 |
|
|
2021
Q2 | $277K | Hold |
750
| – | – | 0.19% | 58 |
|
|
2021
Q1 | $217K | Buy |
+750
| New | +$217K | 0.16% | 60 |
|
|
2020
Q4 | – | Sell |
-750
| Closed | -$170K | – | 75 |
|
|
2020
Q3 | $170K | Hold |
750
| – | – | 0.14% | 64 |
|
|
2020
Q2 | $131K | Hold |
750
| – | – | 0.12% | 71 |
|
|
2020
Q1 | $95K | Hold |
750
| – | – | 0.1% | 72 |
|
|
2019
Q4 | $115K | Hold |
750
| – | – | 0.11% | 77 |
|
|
2019
Q3 | $99K | Hold |
750
| – | – | 0.1% | 78 |
|
|
2019
Q2 | $106K | Hold |
750
| – | – | 0.11% | 76 |
|
|
2019
Q1 | $109K | Hold |
750
| – | – | 0.11% | 79 |
|
|
2018
Q4 | $85K | Hold |
750
| – | – | 0.09% | 84 |
|
|
2018
Q3 | $101K | Hold |
750
| – | – | 0.09% | 79 |
|
|
2018
Q2 | $84K | Hold |
750
| – | – | 0.08% | 84 |
|
|
2018
Q1 | $80K | Hold |
750
| – | – | 0.08% | 89 |
|
|
2017
Q4 | $82K | Buy |
+750
| New | +$82K | 0.08% | 84 |
|